BioElectronics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	0	0.11	0.05	0.09	0.01
Cash & Short-Term Investments	0	0.11	0.05	0.09	0.01
Cash Growth	-99.16%	137.28%	-50.28%	944.59%	54.03%
Receivables	0.06	0.16	0.19	0.06	0.02
Inventory	0.03	0.15	0.1	0.29	0.44
Other Current Assets	-	-	0.01	0.02	0.03
Total Current Assets	0.08	0.43	0.34	0.47	0.5
Property, Plant & Equipment	-	-	-	0	0
Total Assets	0.08	0.43	0.34	0.47	0.5
Accounts Payable	0.65	0.73	1.82	0.96	0.95
Accrued Expenses	0.63	0.63	-	-	-
Short-Term Debt	-	-	0.12	-	-
Current Portion of Long-Term Debt	4.07	6.47	7.04	7.31	4.62
Current Unearned Revenue	0.09	0.54	0.3	0.54	0.03
Other Current Liabilities	0.48	0.46	-	-	-
Total Current Liabilities	5.93	8.84	9.28	8.8	5.59
Long-Term Debt	9.27	6.7	5.64	4.69	5.59
Total Liabilities	15.2	15.55	14.92	13.49	11.19
Common Stock	24.38	24.13	22.92	20.71	18.99
Additional Paid-In Capital	-	-	-	1.03	2.1
Retained Earnings	-38.31	-38.25	-37.09	-34.76	-31.77
Comprehensive Income & Other	-1.19	-1.01	-0.41	-	-
Shareholders' Equity	-15.12	-15.12	-14.57	-13.02	-10.68
Total Liabilities & Equity	0.08	0.43	0.34	0.47	0.5
Total Debt	13.34	13.18	12.8	12	10.21
Net Cash (Debt)	-13.34	-13.07	-12.75	-11.91	-10.2
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	24,379	24,672	22,918	20,706	18,992
Total Common Shares Outstanding	24,379	24,672	22,918	20,706	18,992
Working Capital	-5.85	-8.42	-8.94	-8.34	-5.09
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-15.12	-15.12	-14.57	-13.02	-10.68
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Machinery	0.17	0.17	0.17	0.17	0.17
Leasehold Improvements	0.01	0.01	0.01	0.01	0.01